Sign in to view content

A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma

Prithvi Mruthyunjaya, MD, MHS

Video
Published 2021

Related

Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Annual Meeting Talks
2021
Eye Physics (EP) Plaques for Uveal Melanoma: Initial 12- and 24-month results in a private practice setting performed by a young surgeon
David A Reichstein, MD
On Demand Cases, Courses, and Papers
2019
Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Updates from the Field
2021

Category: Ocular Oncology

See more